STEPHEN T WORLAND Insider Trading $ANDS ANADYS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEPHEN T WORLAND.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN T WORLAND. STEPHEN T WORLAND is EVP, Pharmaceuticals in ANADYS PHARMACEUTICALS INC ($ANDS) and EVP, Research and Development in ANADYS PHARMACEUTICALS INC ($ANDS) and President and CEO in ANADYS PHARMACEUTICALS INC ($ANDS) and President, Pharmaceuticals in ANADYS PHARMACEUTICALS INC ($ANDS).
STEPHEN T WORLAND in ANADYS PHARMACEUTICALS INC
Trading Symbol: ANDSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN T WORLAND: President and CEO, President, Pharmaceuticals, EVP, Pharmaceuticals, EVP, Research and Development
Holdings: 72,317 shares
Latest Transaction: Dec 12 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEPHEN T WORLAND in ANADYS PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 12 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 1.99 | 100,000 | 199,000 | 100,000 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | M | 2.95 | 16,200 | 47,790 | 70,075 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | M | 2.95 | 17,651 | 52,070 | 37,249 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | M | 2.95 | 47 | 139 | 136,530 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | M | 2.95 | 16,200 | 47,790 | 72,317 | 56.1 K to 72.3 K (+28.87 %) |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | M | 2.95 | 17,651 | 52,070 | 56,117 | 38.5 K to 56.1 K (+45.89 %) |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | M | 2.95 | 47 | 139 | 38,466 | 38.4 K to 38.5 K (+0.12 %) |
Dec 11 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 2.00 | 75,000 | 150,000 | 75,000 | |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 2.32 | 100,000 | 232,000 | 100,000 | |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 2.32 | 100,000 | 232,000 | 100,000 | |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.34 | 895 | 2,094 | 208,704 | 207.8 K to 208.7 K (+0.43 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.35 | 12,341 | 29,001 | 207,809 | 195.5 K to 207.8 K (+6.31 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.15 | 19 | 41 | 195,468 | 195.4 K to 195.5 K (+0.01 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.13 | 1,042 | 2,219 | 195,449 | 194.4 K to 195.4 K (+0.54 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.10 | 1,800 | 3,780 | 194,407 | 192.6 K to 194.4 K (+0.93 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.08 | 3,120 | 6,490 | 192,607 | 189.5 K to 192.6 K (+1.65 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.12 | 6,219 | 13,184 | 189,487 | 183.3 K to 189.5 K (+3.39 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.00 | 124,564 | 249,128 | 183,268 | 58.7 K to 183.3 K (+212.19 %) |
Jan 16 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President, Pharmace ... | Option Exercise | M | 2.95 | 25,000 | 73,750 | 136,577 | |
Jan 16 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President, Pharmace ... | Buy | M | 2.95 | 25,000 | 73,750 | 27,586 | 2.6 K to 27.6 K (+966.74 %) |
Dec 12 2006 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President, Pharmace ... | Option Exercise | A | 4.88 | 100,000 | 488,000 | 100,000 | |
Mar 17 2006 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Pharmaceutical ... | Sell | S | 16.00 | 4,000 | 64,000 | 58,704 | 62.7 K to 58.7 K (-6.38 %) |
Mar 06 2006 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Pharmaceutical ... | Sell | S | 14.00 | 3,000 | 42,000 | 63,083 | 66.1 K to 63.1 K (-4.54 %) |
Dec 16 2005 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Option Exercise | A | 8.16 | 110,000 | 897,600 | 110,000 | |
Jun 02 2005 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Option Exercise | M | 2.95 | 25,400 | 74,930 | 196,078 | |
Jun 02 2005 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Buy | M | 2.95 | 25,400 | 74,930 | 26,352 | 952 to 26.4 K (+2,668.07 %) |
Dec 17 2004 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Option Exercise | A | 5.30 | 50,000 | 265,000 | 50,000 |
Page: 1